Management of Embolic Stroke of Undetermined Source (ESUS)

被引:16
作者
Geisler, Tobias [1 ]
Mengel, Annerose [2 ]
Ziemann, Ulf [2 ]
Poli, Sven [2 ]
机构
[1] Univ Hosp Tubingen, Dept Cardiol, Otfried Muller Str 10, D-72076 Tubingen, Germany
[2] Univ Hosp Tubingen, Dept Neurol & Stroke, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
关键词
TRANSIENT ISCHEMIC ATTACK; PATENT FORAMEN OVALE; ATRIAL-FIBRILLATION; CRYPTOGENIC STROKE; SUBGROUP ANALYSIS; MINOR STROKE; ANTIPLATELET THERAPY; ORAL ANTICOAGULANTS; YOUNG-ADULTS; DOUBLE-BLIND;
D O I
10.1007/s40265-018-0912-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
According to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification, embolic stroke of undetermined source (ESUS) has refined the old definition of cryptogenic stroke. More sophisticated criteria and a well-defined diagnostic workup point out the embolic nature of this disease. Because ESUS is associated with a high stroke recurrence, a clear risk prediction and management is of utmost importance to improve prognosis. To date, standard pharmacotherapy consists of antiplatelet drugs and statins. This review attempts to provide an overview on the diagnostic criteria, prognosis, and current clinical trials evaluating the value of direct oral anticoagulants for secondary prevention after ESUS.
引用
收藏
页码:823 / 831
页数:9
相关论文
共 57 条
[1]   The ASCOD Phenotyping of Ischemic Stroke (Updated ASCO Phenotyping) [J].
Amarenco, P. ;
Bogousslavsky, J. ;
Caplan, R. ;
Donnan, G. A. ;
Wolf, M. E. ;
Hennerici, M. G. .
CEREBROVASCULAR DISEASES, 2013, 36 (01) :1-5
[2]   Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source [J].
Amarenco, Pierre ;
Albers, Gregory W. ;
Denison, Hans ;
Easton, J. Donald ;
Evans, Scott R. ;
Held, Peter ;
Hill, Michael D. ;
Jonasson, Jenny ;
Kasner, Scott E. ;
Ladenvall, Per ;
Minematsu, Kazuo ;
Molina, Carlos A. ;
Wang, Yongjun ;
Wong, K. S. Lawrence ;
Johnston, S. Claiborne .
STROKE, 2017, 48 (09) :2480-+
[3]   A computerized algorithm for etiologic classification of ischemic stroke - The causative classification of stroke system [J].
Ay, Hakan ;
Benner, Thomas ;
Arsava, E. Murat ;
Furie, Karen L. ;
Singhal, Aneesh B. ;
Jensen, Matt B. ;
Ayata, Cenk ;
Towfighi, Amytis ;
Smith, Eric E. ;
Chong, Ji Y. ;
Koroshetz, Walter J. ;
Sorensen, A. Gregory .
STROKE, 2007, 38 (11) :2979-2984
[4]   High Rate of Magnetic Resonance Imaging Stroke Recurrence in Cryptogenic Transient Ischemic Attack and Minor Stroke Patients [J].
Bal, Simerpreet ;
Patel, Shiel K. ;
Almekhlafi, Mohammed ;
Modi, Jayesh ;
Demchuk, Andrew M. ;
Coutts, Shelagh B. .
STROKE, 2012, 43 (12) :3387-3388
[5]   Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke [J].
Benavente, Oscar R. ;
Hart, Robert G. ;
McClure, Leslie A. ;
Szychowski, Jeffrey M. ;
Coffey, Christopher S. ;
Pearce, Lesly A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :817-825
[6]   Embolic stroke of undetermined source: a therapeutic target? [J].
Dennis, Martin .
LANCET NEUROLOGY, 2014, 13 (04) :344-346
[7]  
Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X
[8]   Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS) [J].
Diener, Hans-Christoph ;
Easton, J. Donald ;
Granger, Christopher B. ;
Cronin, Lisa ;
Duffy, Christine ;
Cotton, Daniel ;
Brueckmann, Martina ;
Sacco, Ralph L. .
INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (08) :1309-1312
[9]   Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial [J].
Diener, Hans-Christoph ;
Eikelboom, John ;
Connolly, Stuart J. ;
Joyner, Campbell D. ;
Hart, Robert G. ;
Lip, Gregory Y. H. ;
O'Donnell, Martin ;
Hohnloser, Stefan H. ;
Hankey, GraemeJ ;
Shestakovska, Olga ;
Yusuf, Salim .
LANCET NEUROLOGY, 2012, 11 (03) :225-231
[10]   Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [J].
Diener, HC ;
Bogousslavsky, J ;
Brass, LM ;
Cimminiello, C ;
Csiba, L ;
Kaste, M ;
Leys, D ;
Matias-Guiv, J ;
Rupprecht, HJ .
LANCET, 2004, 364 (9431) :331-337